Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?

Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
Clin Exp Rheumatol. 2020 May-Jun;38(3):579
Authors: Bilia S, Giannini D, Rizzelli GML, Tavoni A
PMID: 32456767 [PubMed - in process]

Source: Clinical and Experimental Rheumatology - May 29, 2020 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research